Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Spironolactone + Dapagliflozin
DRUG
2 trials
Sponsors
Universidade do Porto
, University College, London
Conditions
Aortic Stenosis
Heart Failure With Preserved Ejection Fraction
Phase 2
Dapagliflozin With or Without Spironolactone for HFpEF
Completed
NCT05676684
Universidade do Porto
Heart Failure With Preserved Ejection Fraction
Start: 2022-09-15
End: 2024-11-29
Updated: 2025-08-17
Regression in Left Ventricular Hypertrophy and Fibrosis in Aortic Stenosis
Not yet recruiting
NCT07539259
University College, London
Aortic Stenosis
Start: 2026-12-01
End: 2030-02-28
Target: 445
Updated: 2026-09-11
Related Papers
Sodium-Glucose Cotransporter 2 Inhibitor With and Without an Aldosterone Antagonist for Heart Failure With Preserved Ejection Fraction: The SOGALDI-PEF Trial.
2025-08-01
6 citations
SGLT2 inhibitor with and without ALDosterone AntagonIst for heart failure with preserved ejection fraction: Design paper
ESC Heart Failure
2025-05-19
3 citations